There (9A2) Fair Value & Analysis
Other · DE · Market cap €8.5B
Fair value as of: Aug 13, 2026
From 9 valuation models · updated today
Share price +2.8% over the past month.
Below-average quality, screening 161% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (37/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (€31.66). The market is more pessimistic than our downside scenario.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range €9.51 – €20.12 · fair‑value band €31.66 – €52.76 · the €16.18 price screens below the €42.21 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
There (9A2) currently trades at €16.18, while our model-based Fair Value estimate is €42.21, implying the stock looks roughly 160.9% undervalued today. The Quality Score stands at 37/100 (below-average quality), in the Other sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Net debt stands at €15.4B. Fundamentals as of Aug 13, 2026
Our scenario range runs from €31.66 (bear case) to €52.76 (bull case); at €16.18, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 12% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Other peers we cover trades at -52% fair-value upside, at 161%, 9A2 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: Growth Earnings (€46.96) versus Asset-Based (€18.34). Highest evidence: Residual Income (76).
Notify me when 9A2 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 39 · Market factors (momentum, volatility) 55
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
There is no Profile data available for 9A2.BE.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
There reported revenue of €1.5B in FY2025 versus €1.7B in FY2021, a compound −2.7%/yr. Reported net income was €1.3B in FY2025, compounding −4.6%/yr from FY2021.
Watch 9A2: get an alert when its fair value changes →
Peer Group
Other · 386 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Other median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Other stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Federal Home Loan Mortgage Corporation FREJO | $15.58 | $51.90 | +233% |
| 533278 533278 | ₹409.15 | ₹660.78 | +62% |
| Nestl?? India Limited 500790 | ₹1,497 | ₹191.93 | -87% |
| ITC Limited 500875 | ₹279.50 | ₹212.74 | -24% |
| 540376 540376 | ₹4,044 | ₹1,538 | -62% |
| 540777 540777 | ₹536.00 | ₹149.72 | -72% |
| Lupin Limited 500257 | ₹2,265 | ₹1,983 | -12% |
| Dabur India Limited 500096 | ₹413.80 | ₹122.93 | -70% |
| 540719 540719 | ₹1,835 | ₹872.41 | -52% |
| Britannia Industries Limited 500825 | ₹5,626 | ₹1,289 | -77% |
Compare There with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is There (9A2) overvalued or undervalued?
What is the fair value of 9A2?
What is the quality score of 9A2?
What is the net profit margin of 9A2?
Does There pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track There and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.